Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-07-12
2005-07-12
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
53, 53
Reexamination Certificate
active
06916795
ABSTRACT:
Compositions comprising the nucleotides adenosine diphosphate and adenosine monophosphate, and their use for neutralizing effects of excess incident energy on the human body, particularly effects of ionizing radiation from nuclear or radiological energy sources, are disclosed and claimed.
REFERENCES:
Tikhomirova et al., “Comparative Radioprotective Effect of Adenylates Against Short-Term and Long-Term γ-Radiation,”Radiobiologiya, 23(1), 100-104 (Sep.-Oct., 1983);Chemical Abstracts, 98, HCAPlus & CA Abstr. No. 157174 (1983); only HCAPlus Abstract supplied; applicant copy; see PTO-1449 AW).
Grozdov, S. P., “Comparative Study of the Therapeutice Effect of Adenyl Compounds and their effect on Metabolism in Radiation Sickness,”Radiobiologiya, 20(4), 524-530 (1980);Chemical Abstracts, 93, Abstract No. 179729 (HCAPlus No. 579729) (1980).
Pantev et al., “Antiradiation Mixture and Ionic-bond of AET and Adenyl Nucleotides,”Strahlentherapie und Onkologie, 167(7), 422-426 (Jul., 1991);Medline No. 91313485; only Medline Abstract supplied; applicant copy; see PTO-1449 AT).
Koshcheenko, N. N., “Biochemical Mechanism of the Radioprotective Action of Adenylic Compounds,”Nauchnye Doklady Vysshei Shkoly Biologicheskie,(Issue No. 2), pp. 5-18 (1992);Medline No. 82161127; only Medline title and citation supplied.
Ivnitsky et al., “Mechanisms of Cerebral Radiation Syndrome,”Radiatsionnaya Biologiya, Radioekologiya, 41(1), 48-55 (2001);Chemical Abstracts, 135, Abstr. No. 269359 (HCAPlus No. 271063) (2001; only HCAPlus Abstract supplied.
Nosov et al., “Metabolic Correction of Cerebral Radiation Syndrome,”Radiation Research, 152(5), 523-529 (1999);Chemical Abstracts, 132, Abstr. No. 20542 (HCAPlus No. 714176) (1999).
Pospilsil et al., “Radioprotection of Mouse Hemopoiesis by Dipyridamole and Adenosine Monophospohate in Fractionated Treatment,”Radiation Research, 142(1), 16-22 (1995);Chemical Abstracts, 122, Abstr. No. 259989 (HCAPlus No. 487342 ) (1999).
Grozdov et al., “Influence of ADP on the Course of Radiation Sickness and Some Metabolic Processes in Rats After Irradiaiton of the Abdomen and Parenteral Feeding,”Radiobiologiya, 25(2), 234-238 (1985);Chemical Abstracts, 103, Abstr. No. 2971 (HCAPlus No. 402971 ) (1985).
Savitskii et al., “Liver 5-Nucleotidase Activity of Rats with Radiation Sickness and Under Administration of ATP,”Radiobiologiya, 20(1), 103-106 (1980);Chemical Abstracts, 92, Abstr. No. 193556 (HCAPlus No. 193556) (1980).
Nikolov et al., “Therapeutic Effect of Adenosine Triphoshate Upon Survival Rate of Irradiated Rats,”Rentgenologiya i Radiologiya, 8(4), 209-214 (1969);Chemical Abstracts, 74, Abstr. No. 72504 (HCAPlus No. 72504) (1971).
Rogozkin et al., “Adenosine Triphosphoric Acid as Prophylactic and Therapeutic Drug During Radiation Sickness,”Suvremenna Meditsina, 21(6), 12-18 (1970);Chemical Abstracts, 74, Abstr. No. 10149 (HCAPlus No. 10149) (1971); only HCAPlus Abstract supplied.
Wagner et al., “Chemical Protection Against X-Radiation in the Guinea Pig. I. Radioprotective Action of RNA and ATP,”International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 12(2), 101-112 (1967);Chemical Abstracts, 67, Abstr. No. 70960 (HCAPlus No. 470960) (1967); only HCAPlus Abstract supplied.
Cantley, Jr., et al., “Vanadate Is a Potent (Na,K)-ATPase Inhibitor Found in ATP Derived From Muscle,”Journal of Biological Chemistry, 252(21), 7421-7423 (Nov. 10, 1977).
Beaugé et al., “A Modifier of (Na++ K+) ATPase in Commercial ATP,”Nature, 268, 355-356 (Jul. 28, 1977).
Josephson et al., “Isolation of a Potent (Na-K)ATPase Inhibitor from Striated Muscles,”Biochemistry, 16(21), 4572-4578 (Oct. 18, 1977).
Anon,Sigma Catalog -Biochemicals and Reagents for Life Science Research, 1997, St, Louis, MO, only pp. 65-66 supplied.
Lehninger,Biochemistry, Second Edition, Worth Publishers, Inc., New York NY, Jul., 1978, only pp. 315-316 supplied.
Sugahara et al., “Recovery from Radiation Injury with Nucleotide Mixtures in Mice,”Folia Biol.(Prague),10(6), 461-464 (1964);Chemical Abstracts, 62, Abstr. No. 75954 (HCAPlus No. 75954 ) (1965).
Senagore et al., “Adenosine Triphosphate-Magnesium Chloride in Radiation Injury,”Surgery, 112(5), 933-939 (Nov., 1992);Medline No. 93068804.
Szeinfeld et al., “Response of Normal BALB/c Mouse Tissue to p(66 MeV)/Be Fast Neutron Radiation: Protection by Exogenous ATP,”Strahlentherapie und Onkologie, 168(3), 174-178 (Mar., 1992);Medline Accession No. 92205514.
A. L. Lehninger,Biochemistry, Second Edition, Worth Publisher, Inc., New York, NY, Jul., 1978, only pp. 315, 316 and 400 supplied..
Sigma Chemical Co.,Biochemicals—Organic Compounds—Diagnostic Reagents(1995 Catalog), St. Louis, MO, 1995, only pp. 45-46 supplied.
J. F. Weiss††, “Pharmacologic Approaches to Protection Against Radiation-induced Lethality and Other Damage,”Environmental Health Perspectives, 105(Suppl. 6), 1473-1478 (Dec., 1997).
Venes et al. (eds.),Taber's Cyclopedic Medical Dictionary, 19th Edition, F. A. Davis Co., Philadelphia, PA, 2001, only pp. 1817-1818 supplied.
Sugahara et al., “Recovery from Radiation Injury with Nucleotide Mixtures in Mice,”Folia Biol.(Prague),10(6), 461-464 (1964);Chemical Abstracts, 62, Abstr. No. 75954 (HCAPlus No. 75954 ) (1965); only HCAPlus Abstract supplied.
Kozyreva EV; Eliseenko NN; Iashkin PN; Tikhomirova MV; “Radiobiologiia,” 1977 Sep.-Oct.; 17(5):733-8.
Tikhomirova MV; Rogozkim VD; “Radiobiologiia,” 1979 Mar.-Apr.; 19(2):241-5.
Pantev T; Georgieva R; Topalova S; “Strahlentherapie und Onkologie:Organ der Deutschen Rontgengesellschaft . . . ” 1991 Jul.; 167(7):422-6.
Grant GA; Barlow JA; Leach KE; “Strahlentherapie,” 1976, 152(3):285-91.
Langendorff H; Langendorff M; “International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine,” 1971; 19(5):493-5.
Tikhomirova MV; Iashkin PN; “Radiobiologiia,” Jan.-Feb. 1983; 23(1):100-4.
Langendorff H; Langendorff M; “Strahlentherapie,” 1972, 144(4):451-6 (Oct., 1972).
Langendorff H; “Die Naturwissenschaften,” 1970, 57(9);455 (Sep., 1970).
Crane L. E.
Hoffman Wasson & Gitler
N.R. Youssef, LLC
LandOfFree
Energy-protective composition comprising adenosine phosphates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Energy-protective composition comprising adenosine phosphates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Energy-protective composition comprising adenosine phosphates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3379168